Boston biotech firm Intarcia snags $200 mln

By Iris Dorbian — 2 years ago

Boston-based biotech company Intarcia Therapeutics has raised $200 million financing. RA Capital led the round with participation from investors that include Farallon Capital Management, Foresite Capital, Franklin Templeton, Fred Alger Management, New Leaf Venture Partners and Quilvest.


New Ownership For Contech

By Angela Sormani — 4 years ago

Contech has announced its new owners. Investors Anchorage Capital Group, Littlejohn & Co, Tennenbaum Capital Partners, and Farallon Capital Management have worked with Contech, its equity partners and its senior lenders to recapitalize the company and secure long-term financing. Contech is a provider of site solution products and services for the civil engineering industry. PRESS […]